Results 211 to 220 of about 821,521 (329)

Role of mGlu₅ Receptors and Inhibitory Neurotransmission in M₁ Dependent Muscarinic LTD in the Prefrontal Cortex: Implications in Schizophrenia

, 2017
Ayan Ghoshal, Sean P. Moran, Jonathan W. Dickerson, Max E. Joffe, Brad A. Grueter, Zixiu Xiang, Craig W. Lindsley, Jerri M. Rook, P. Jeffrey Conn   +8 more
openalex   +2 more sources

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Closing Editorial for the Special Issue: "Advanced Treatment of Schizophrenia". [PDF]

Biomedicines
Werner FM, Coveñas R.
europepmc   +1 more source

Does COMT Play a Role in Parkinson's Disease Susceptibility across Diverse Ancestral Populations?

Movement Disorders, EarlyView.
Abstract Background The catechol‐O‐methyltransferase (COMT) gene is involved in brain catecholamine metabolism, but its association with Parkinson's disease (PD) risk remains unclear. Objective Our aim was to investigate the relationship between COMT genetic variants and PD risk across diverse ancestries.
Miguel Martín‐Bórnez, Nisar Shar, Mohamed Ahmed Nour, David Murphy, Inas Elsayed, Megha Shri Nanjundaswamy, Francisca Nwaokorie, Adedunni Olusanya, Nicole Kuznetsov, Sara Bandres‐Ciga, Alastair J. Noyce, Hirotaka Iwaki, Lietsel Jones, Pilar Gómez‐Garre, Pablo Mir, The Global Parkinson's Genetics Program (GP2), María Teresa Periñán   +16 more
wiley   +1 more source

Letter to the Editor in Response to "Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis" by Nishii et al. [PDF]

Neuropsychopharmacol Rep
Farhan M.
europepmc   +1 more source

Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study

Movement Disorders, EarlyView.
Abstract Background Previous studies suggest an association between bipolar disorder (BD) and an increased risk of Parkinson's disease (PD), but the long‐term temporal relationship remains unclear. Particularly, it is unclear whether the risk of PD is influenced by the duration since BD diagnosis.
Elina Jaakkola, Marjaana Koponen, Valtteri Kaasinen, Jarmo Hietala, Sirpa Hartikainen, Anna‐Maija Tolppanen   +5 more
wiley   +1 more source

Dermatoglyphics and schizophrenia: A comprehensive review of neurodevelopmental biomarkers. [PDF]

World J Psychiatry
Bou Farah E, Beydoun K, Nasr L, Chokor Z, Ghanem S, El Fassih I, Akiki S, Moghnieh R, Tlaiss Y, Farhat H.   +9 more
europepmc   +1 more source

ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism

, 2020
Atsuko Nagaoka, Yasuto Kunii, Mizuki Hino, Ryuta Izumi, Chisato Nagashima, Akari Takeshima, Makoto Sainouchi, Hiroyuki Nawa, Akiyoshi Kakita, Hirooki Yabe   +9 more
openalex   +1 more source

Simultaneous Detection of GABA and Glycine Using MEGA‐PRESS With TE Optimization at 3T

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To achieve the simultaneous acquisition of gamma‐aminobutyric acid (GABA) and glycine (Gly) using a MEGA‐PRESS sequence with an optimized TE at 3T. Methods MEGA‐PRESS simulations were performed at TEs 60‐88 ms to determine the optimal TE for Gly detection with minimal myo‐Inositol (mI) overlap and maximal GABA detection sensitivity ...
Justin R. Singer, Kimberly L. Chan
wiley   +1 more source

Abnormal brain network reconfiguration in neuropsychiatric disorders across cognitive decline, Depression, and Schizophrenia. [PDF]

PLoS One
He Y, Yan Z, Liang Y, Yu Y.
europepmc   +1 more source